Internal Medicine, Hematology & Oncology · Omaha, NE
NPI
1184604118
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
7500 Mercy Rd, Suite 1300
Omaha, NE, 68124
Phone (402) 393-3110
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.6M
168,691 services
Medicare patients, 2024
978
Average age 75
Drug cost, 2024
$2.8M
2,052 prescriptions
Company payments, 2025
$248
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Margaret Block was code J1439 (injection, ferric carboxymaltose, 1 mg), 28,500 times for 26 patients. In total Margaret Block billed 168,691 services in 177 codes, and Medicare paid $2.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 28,500 | 26 | $0.87 | $25K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 14,660 | 20 | $2.29 | $34K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 12,400 | 19 | $44.48 | $552K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,900 | 18 | $0.11 | $771 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 4,860 | 12 | $39.43 | $192K |
| J0897 Injection, denosumab, 1 mg | Office | 4,440 | 38 | $20.35 | $90K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 4,092 | 15 | $19.89 | $81K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2,900 | 20 | $35.31 | $102K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,027 | 56 | $0.09 | $180 |
| 85025 Blood Count | Office | 1,941 | 676 | $7.56 | $15K |
| 80053 Clinical Chemistry | Office | 1,502 | 672 | $10.30 | $15K |
| 99214 Office E&M - Established | Office | 1,130 | 578 | $82.50 | $93K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 896 | 29 | $0.07 | $65.94 |
| 86300 Immunoassay | Office | 883 | 510 | $20.32 | $18K |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 572 | 15 | $0.47 | $268 |
By year: 2022 $3.3M for 205,937 services; 2023 $3.7M for 220,321 services; 2024 $2.6M for 168,691 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,941 | 676 | $7.56 | $15K |
| 80053 Clinical Chemistry | 1,502 | 672 | $10.30 | $15K |
| 86300 Immunoassay | 883 | 510 | $20.32 | $18K |
| 85651 Clinical Chemistry | 261 | 134 | $4.18 | $1,091 |
| 83615 Clinical Chemistry | 237 | 106 | $5.80 | $1,373 |
| 83735 Clinical Chemistry | 213 | 31 | $6.11 | $1,301 |
| 80048 Clinical Chemistry | 152 | 57 | $8.24 | $1,253 |
| 84443 Clinical Chemistry | 147 | 45 | $16.46 | $2,420 |
| 84439 Clinical Chemistry | 138 | 41 | $8.84 | $1,220 |
| 82378 Clinical Chemistry | 130 | 46 | $18.29 | $2,378 |
Medicare prescription drug claims, 2024
In 2024, the drug Margaret Block prescribed most often to Medicare patients was Letrozole, with 622 prescriptions and refills. In total Margaret Block wrote 2,052 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 622 | 1,313 | 168 | $9,949 |
| Potassium Chloride Generic | 117 | 168 | 33 | $1,612 |
| Alendronate Sodium Generic | 106 | 216 | 23 | $563 |
| Exemestane Generic | 73 | 115 | 18 | $9,162 |
| Dexamethasone Generic | 71 | 77 | 38 | $1,505 |
| Ondansetron Hcl Generic | 69 | 69 | 39 | $375 |
| Tamoxifen Citrate Generic | 63 | 137 | 18 | $1,350 |
| Gabapentin Generic | 62 | 88 | 19 | $1,050 |
| Prochlorperazine Maleate Generic | 43 | 43 | 32 | $382 |
| Eliquis Apixaban | 42 | 63 | Under 11 | $36K |
| Olanzapine Generic | 41 | 43 | 16 | $129 |
| Levothyroxine Sodium Generic | 36 | 66 | Under 11 | $325 |
| Acyclovir Generic | 32 | 34 | Under 11 | $273 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 31 | 65 | Under 11 | $303 |
| Raloxifene Hcl Generic | 28 | 54 | Under 11 | $936 |
Brand drugs: 277 claims; generic drugs: 1,775 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Margaret Block $248 ($248 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $58.26.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $58.26 |
| Aveo Pharmaceuticals, Inc. | 2 | $40 |
| Recordati_rare_diseases_inc. | 1 | $39.09 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $28.44 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $21 |
| Janssen Biotech, Inc. JNJ | 1 | $17.83 |
| Servier Pharmaceuticals LLC | 1 | $14.98 |
| Pfizer Inc. PFE | 1 | $14.9 |
| Array Biopharma Inc PFE | 1 | $13.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.